This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Influenza A H16N3 Hemagglutinin HA1 Subunit (HA1), C-His
Product Overview
BioVenic's Recombinant Influenza A H16N3 Hemagglutinin HA1 Subunit (HA1), C-His is a recombinant protein expressed from HEK293 Cells. Its predicted molecular weight is 37.5 kDa. The purity is>90% (SDS-PAGE). The endotoxin level is <1 EU/μg (LAL).
Specifications
Target Information
The avian influenza virus subtype H16N3 was first isolated in 1975 and is now detectable in numerous countries around the world. Genetic segments from other species have been incorporated into H16N3, which may influence its pathogenicity and host range, possibly posing a future threat to both animal and human health. The hemagglutinin (HA) protein, a critical glycoprotein of the influenza virus, plays a pivotal role in the early stages of infection. The HA1 subunit, which contains a receptor binding site, facilitates the virus's attachment to specific sialyl sugar chains on the host cell surface.
Shipping and Storage
This product is shipped with dry ice. Avoid repeated freezing and thawing. Store for 4 weeks at 2-8°C, for 12 months at -20°C or -80°C.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquote the reconstituted solution to minimise freeze-thaw cycles.